Results 201 to 210 of about 580,017 (382)
The Three R\u27s of Delayed Hypersensitivity [PDF]
Delayed hypersensitivity is one of several immune responses initiated by thymus-derived (T) lymphocytes. The mononuclear infiltrate of delayed hypersensitivity is a collaborative phenomenon between T lymphocytes and monocytes.
Horwitz, David
core +1 more source
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors.
Omar Hasan Ali+10 more
semanticscholar +1 more source
Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis. [PDF]
Liana Harvath+4 more
openalex +1 more source
Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail+5 more
wiley +1 more source
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. [PDF]
Dendritic cells comprise a system of highly efficient antigen-presenting cells involved in the initiation of T cell responses. Herein, we investigated the role of the CD28 pathway during alloreactive T cell proliferation induced by dendritic-Langerhans ...
Azuma, M+6 more
core
Human leukocyte antigen class I-independent pathways may contribute to hepatitis B virus-induced liver disease after liver transplantation [PDF]
Gabriele Missale+4 more
openalex +1 more source
This study introduces an immunomodulatory DNA tetrahedral framework nucleic acid‐based nanovaccine tFNA‐CpG. The functionalized nanovaccine shows stable and well‐defined morphological characteristics and can be efficiently taken up by APCs. When combined with the immune checkpoint inhibitor anti‐PD‐1, it notably ameliorated the immunosuppressive ...
Xueting Yang+12 more
wiley +1 more source
iPRISM: Intelligent Predicting Response to Cancer Immunotherapy through Systematic Modeling
The Intelligent Predicting Response to cancer Immunotherapy through Systematic Modeling (iPRISM) model uses data from genes and immune responses to predict how well cancer patients will respond to immunotherapy. Tested on multiple cancer types, iPRISM shows higher accuracy compared to existing methods.
Yinchun Su+7 more
wiley +1 more source